SOURCE: Vivione Biosciences Inc.

Vivione Biosciences

November 10, 2015 13:20 ET

Vivione Biosciences Inc. Announces Resignation of Director Lal Narang

CALGARY, AB--(Marketwired - November 10, 2015) - Vivione Biosciences Inc. ("Vivione" or the "Corporation") (NEX BOARD: VBI.H) announces that effective November 9, 2015, Lal Narang has resigned from the board of directors of the Corporation.

The Corporation would like to thank Mr. Narang for his service and wishes him well in his future endeavors.

About Vivione

Vivione's business is centered on the commercialization of the RAPID-B technology, which is an integrated system of hardware, software and chemical reagents that tests bacteria in key environments. This technology could have potentially diverse applicability from food safety to clinical diagnostics, by identifying and quantifying microorganism levels more rapidly and with greater precision than currently employed techniques.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Contact Information